Welcome to InnovAge Holding Corp. (NASDAQ:INNV) Q2 2025 Results Earnings Conference Call
February 4, 2025 5:00 PM ET
Company Participants:
Ryan Kubota – Director of Investor Relations
Patrick Blair – Chief Executive Officer
Ben Adams – Chief Financial Officer
Richard Feifer – Chief Medical Officer
Conference Call Participants:
Jamie Perse – Goldman Sachs
Jared Haase – William Blair
Matthew Gilmore – KeyBanc Capital Markets
Benjamin Rossi – J.P. Morgan
Welcome to InnovAge Second Quarter 2025 Earnings Conference Call. Today, we will be discussing our financial results for the second quarter of 2025, as well as our strategic initiatives moving forward.
Ryan Kubota, Director of Investor Relations, will kick off the call by providing an overview of our financial performance during the quarter. Patrick Blair, our Chief Executive Officer, will then discuss our key accomplishments and milestones achieved. Ben Adams, our Chief Financial Officer, will delve into the numbers and provide detailed insights into our financials. Lastly, Richard Feifer, our Chief Medical Officer, will elaborate on our healthcare initiatives and the impact on patient care.
We will then open the call for questions from our conference call participants, including Jamie Perse from Goldman Sachs, Jared Haase from William Blair, Matthew Gilmore from KeyBanc Capital Markets, and Benjamin Rossi from J.P. Morgan.
How InnovAge Holding Corp.’s Q2 2025 Results Will Affect Me:
As an investor in InnovAge Holding Corp., the Q2 2025 results provide valuable insights into the company’s financial health and performance. This information can help me make informed decisions about my investment in the company and understand the potential ROI moving forward.
How InnovAge Holding Corp.’s Q2 2025 Results Will Affect the World:
As a leading healthcare company, InnovAge Holding Corp.’s initiatives and financial results can have a significant impact on the healthcare industry and patient care globally. The innovations and advancements made by the company can potentially improve outcomes for patients and drive positive change in the healthcare landscape.
Conclusion:
In conclusion, InnovAge Holding Corp.’s Q2 2025 results showcase the company’s commitment to financial success and healthcare innovation. Moving forward, the company remains focused on driving growth, improving patient care, and delivering value to its shareholders. Thank you for joining us on this earnings conference call.
